Improving the Selection Model of Essential Medicines in China by Evidence-based Thinking

Abstract

Objective To sort out the problems in the selection model of essential medicines in China, and to put forward some suggestions to optimize the selection model to ensure the rationality of the medicines in the essential medicines list. Methods The domestic and foreign literature on the selection of essential medicines was reviewed. Then, the opinions on the selection methods and results of essential medicines from foreign literature were investigated to make a comparison with the selection of essential medicines in China. Finally, the general and special laws of the selection process of the essential medicines were explored. Results and Conclusion It is recommended that the selection model of essential medicines in China should be further optimized, and the evidence-based thinking and methods should be utilized to enhance the scientific nature of the selection process.

Keywords

essential medicine / evidence-based thinking / comparative study

References

[1] Li Youping, Yang Kehu. Evidence-Based Medicine[M]. Beijing: People’s Medical Publishing House, 2021: 65.

[2] Li Youping. Practical Evidence-Based Medicine[M]. Beijing: People’s Medical Publishing House, 2018: 30.

[3] Yang Xuewen, Qiu Bo. From empirical medicine to evidence-based medicine: An inevitable outcome of clinical medicine development[J]. Hospital Directors’ Forum, 2013, 10 (4): 34-35.

[4] National Healthcare Security Administration. Announcement of the National Medical Security Administration on the announcement of the “2021 National Medical Insurance Drug Catalog Adjustment Work Plan” and “2021 National Medical Insurance Drug Catalog Adjustment Application Guidelines” [EB/OL].(2021-12-03)[2022-05-21]. http://www.nhsa.gov.cn/art/2021/6/30/art_62_5386.html.

[5] National Health Commission of the People’s Republic of China. Announcement on Public Comments on the Administrative Measures for the National Essential Medicines List (Revised Draft)[EB/OL]. (2021-11-15)[2022-05-21]. http://www.nhc.gov.cn/wjw/yjzj/202111/068c31b85cb7486b9f77057b3e358aae.shtml.

[6] He Yuan. Research and enlightenment of enterprise standardization management[J]. China Quality and Standards Herald, 2021 (1): 30-32.

[7] He Defang. Analysis of obstacles and countermeasures for the development of China’s expert consultation system[J]. China Soft Science, 2008 (7): 20-26.

[8] Chen Dongmei. Developing evidence-based medicine to promote clinical practice[J]. Medical Equipment, 2015, 28 (8): 42-43.

[9] National Health Commission of the People’s Republic of China. Notice on Printing and Distributing the Administrative Measures for the National Essential Drug Catalogue[EB/OL]. (2015-04-14)[2022-05-21]. http://www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm?id=8147002103b741179217eced1ad77efc.

[10] Li Youping, Li Jing, Sun Xin, et al. The origin and development of evidence-based medicine in China: Dedicated to the 20th anniversary of evidence-based medicine in China[J]. China Journal of Evidence-Based Medicine, 2016, 16 (1): 2-6.

[11] Sun Lihua. Pharmacoeconomics[M]. Beijing: China Medical Science and Technology Press, 2019: 1.

[12] Zhao Menglu. Investigation of return-to-work readiness and maintenance of young and middle-aged stroke patients and construction of prediction model[D]. Qingdao University, 2021.